255 related articles for article (PubMed ID: 19903847)
1. Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor.
Kuo PC; Tsao YP; Chang HW; Chen PH; Huang CW; Lin ST; Weng YT; Tsai TC; Shieh SY; Chen SL
Cancer Res; 2009 Dec; 69(23):8877-85. PubMed ID: 19903847
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of estrogen receptor transcriptional activity by breast cancer amplified sequence 2.
Qi C; Zhu YT; Chang J; Yeldandi AV; Rao MS; Zhu YJ
Biochem Biophys Res Commun; 2005 Mar; 328(2):393-8. PubMed ID: 15694360
[TBL] [Abstract][Full Text] [Related]
3. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer.
Yang H; Wen YY; Zhao R; Lin YL; Fournier K; Yang HY; Qiu Y; Diaz J; Laronga C; Lee MH
Cancer Res; 2006 Mar; 66(6):3096-105. PubMed ID: 16540659
[TBL] [Abstract][Full Text] [Related]
4. Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells.
Yan W; Chen X
Cancer Res; 2007 Oct; 67(19):9117-24. PubMed ID: 17909016
[TBL] [Abstract][Full Text] [Related]
5. Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis.
Park K; Kim K; Rho SB; Choi K; Kim D; Oh SH; Park J; Lee SH; Lee JH
Cancer Res; 2005 Feb; 65(3):749-57. PubMed ID: 15705871
[TBL] [Abstract][Full Text] [Related]
6. The autocrine human secreted PDZ domain-containing protein 2 (sPDZD2) induces senescence or quiescence of prostate, breast and liver cancer cells via transcriptional activation of p53.
Tam CW; Liu VW; Leung WY; Yao KM; Shiu SY
Cancer Lett; 2008 Nov; 271(1):64-80. PubMed ID: 18639375
[TBL] [Abstract][Full Text] [Related]
7. Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis.
Li N; Zheng Y; Chen W; Wang C; Liu X; He W; Xu H; Cao X
Cancer Res; 2007 Dec; 67(23):11176-85. PubMed ID: 18056442
[TBL] [Abstract][Full Text] [Related]
8. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
Mannefeld M; Klassen E; Gaubatz S
Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
10. Skp2 suppresses p53-dependent apoptosis by inhibiting p300.
Kitagawa M; Lee SH; McCormick F
Mol Cell; 2008 Feb; 29(2):217-31. PubMed ID: 18243116
[TBL] [Abstract][Full Text] [Related]
11. p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.
Singh K; Mogare D; Giridharagopalan RO; Gogiraju R; Pande G; Chattopadhyay S
PLoS One; 2007 Aug; 2(7):e660. PubMed ID: 17668048
[TBL] [Abstract][Full Text] [Related]
12. Novel small molecule induces p53-dependent apoptosis in human colon cancer cells.
Park SE; Min YK; Ha JD; Kim BT; Lee WG
Biochem Biophys Res Commun; 2007 Jul; 358(3):842-7. PubMed ID: 17509529
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of DNA binding and transcriptional regulatory function of an endogenous mutant p53 in MDA-468 human breast cancer cells.
Prasad KA; Church JG
Biochem Biophys Res Commun; 1997 Mar; 232(1):14-9. PubMed ID: 9125118
[TBL] [Abstract][Full Text] [Related]
14. A novel domain of BRCA1 interacts with p53 in breast cancer cells.
Buck M
Cancer Lett; 2008 Sep; 268(1):137-45. PubMed ID: 18501503
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
[TBL] [Abstract][Full Text] [Related]
16. Identification of ANKRD11 as a p53 coactivator.
Neilsen PM; Cheney KM; Li CW; Chen JD; Cawrse JE; Schulz RB; Powell JA; Kumar R; Callen DF
J Cell Sci; 2008 Nov; 121(Pt 21):3541-52. PubMed ID: 18840648
[TBL] [Abstract][Full Text] [Related]
17. Human Spot 14 protein is a p53-dependent transcriptional coactivator via the recruitment of thyroid receptor and Zac1.
Chou WY; Ho CL; Tseng ML; Liu ST; Yen LC; Huang SM
Int J Biochem Cell Biol; 2008; 40(9):1826-34. PubMed ID: 18299245
[TBL] [Abstract][Full Text] [Related]
18. Microtubule-associated protein 1B light chain (MAP1B-LC1) negatively regulates the activity of tumor suppressor p53 in neuroblastoma cells.
Lee SY; Kim JW; Jeong MH; An JH; Jang SM; Song KH; Choi KH
FEBS Lett; 2008 Aug; 582(19):2826-32. PubMed ID: 18656471
[TBL] [Abstract][Full Text] [Related]
19. XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification.
Zou B; Chim CS; Pang R; Zeng H; Dai Y; Zhang R; Lam CS; Tan VP; Hung IF; Lan HY; Wong BC
Mol Carcinog; 2012 May; 51(5):422-32. PubMed ID: 21678496
[TBL] [Abstract][Full Text] [Related]
20. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
Montano X
Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
